The Global Resource For Connecting Buyers and Sellers

Abide Therapeutics to Participate in February 2018 Investor Conferences

SAN DIEGO, Feb. 7, 2018 /PRNewswire/ — Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced today that Alan Ezekowitz, CEO and President, will present an overview of the company…